NCT05489965 Gender Disparities in Voice Outcomes After Tracheoesophageal Puncture in Total Laryngectomy Patients (UC Davis) Status RECRUITING Phase N/A
NCT05289661 Descemet Endothelial Thickness Comparison Trial I Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05286203 Ocular Pathogen and Transcriptome Investigation Using Comprehensive Sequencing Status COMPLETED Phase NA
NCT05112185 Childcare Healthy Beverage Access, Food and Beverage Intake, and Obesity Status COMPLETED Phase NA
NCT05110781 Atezolizumab Before Surgery for the Treatment of Regionally Metastatic Head and Neck Squamous Cell Cancer With an Unknown or Historic Primary Site Status TERMINATED Phase PHASE2
NCT05101356 A Cancer Vaccine (Labvax 3(22)-23) and GM-CSF Alone or in Combination With Pembrolizumab for the Treatment of Advanced Stage Adenocarcinoma Status SUSPENDED Phase PHASE1/PHASE2
NCT05074238 Influence of Sun Protection and Linear Repair of Cutaneous Surgical Defects Status ACTIVE_NOT_RECRUITING Phase NA
NCT05074212 Aesthetic Outcome of Complex Linear Closure vs Second Intention Healing: Below the Knee Status COMPLETED Phase NA
NCT05056077 Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit) Status ACTIVE_NOT_RECRUITING Phase NA
NCT05052528 Fludarabine and Cyclophosphamide With or Without Rituximab Before CD19 Chimeric Antigen Receptor T Cells for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma Status RECRUITING Phase PHASE1
NCT05021029 UC Davis Cohort of Pre-Malignant and Malignant Gastro-Intestinal DisEases Study Status ENROLLING_BY_INVITATION Phase N/A
NCT04895956 Intra-sheath vs Extra-sheath Injection for De Quervain's Tenosynovitis Status RECRUITING Phase PHASE4
NCT04850287 Improving Health Awareness Using Social Network Interventions Status ACTIVE_NOT_RECRUITING Phase NA
NCT04587687 Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma Status RECRUITING Phase PHASE2
NCT04545762 Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma Status RECRUITING Phase PHASE1